Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-377-1 | CAS number: 106-24-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- repeated dose toxicity: dermal
- Remarks:
- combined repeated dose and reproduction / developmental screening
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: acc. to OECD guideline and GLP
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 421 (Reproduction/Developmental Toxicity Screening test)
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OPPTS 870.3550 (Reproduction/Developmental Toxicity Screening Test)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Geraniol
- EC Number:
- 203-377-1
- EC Name:
- Geraniol
- Cas Number:
- 106-24-1
- Molecular formula:
- C10H18O
- IUPAC Name:
- 3,7-dimethylocta-2,6-dien-1-ol
- Details on test material:
- liquid, colorless, clear
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services GmbH, Germany
- Age at study initiation: about 11-12 weeks
- Housing: Makrolon cage type M III
- No. of animals per cage: 1 animal,
- Exceptions: during mating: 1 male/ 1 female per cage; during rearing up to PND4: 1 dam with her litter
- Enrichment: Wooden gnawing blocks (Type NGM E-022)
- Bedding: Type Lignocel PS 14 fibres, dustfree bedding
- Diet: Ground Kliba maintenance diet mouse/rat "GLP"; ad libitum
- Water: ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12:12
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- corn oil
- Details on exposure:
- - Preparation frequency: The preparations were prepared at intervals for which the stability is guaranteed (7 days).
- Application area: Intact clipped skin of the back (dorsal and dorsolateral areas of the trunk; not less than 10% of the body surface); the first clipping was carried out at least 24 hours before the randomization. The rats were reclipped at least once a week (depending on the hair growth).
- Type of application: Dermal application of the test-substance preparations to the clipped intact dorsal skin by means was carried out with 3-mL syringes (3CC Syringe, supplied by Becton, Dickinson & Co., Franklin Lakes, U.S.A.) and a semiocclusive dressing (4 layers of absorbent gauze) and stretch bandage)). The test-substance preparation was applied to the dorsal skin with the syringe in each case. After removal of the dressing, the application area was washed with lukewarm water.
- Volume to be applied: 4 mL/kg body weight (related to the body weight determined most recently in each case) - Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- Mating details:
- M/F ratio per cage: 1:1
- Length of cohabitation: up tp 14 days
Application period:
Males: From day 0 (start of administration period) until sacrifice
Females: From day 0 (start of administration period) until GD 19
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy - Frequency of treatment:
- daily for at least 6 hours
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
450 mg/kg bw/d
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
300 mg/kg bw/d
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
150 mg/kg bw/d
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
50 mg/kg bw/d
Basis:
nominal per unit body weight
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
A check for moribund and dead animals was made twice daily on working days and once daily on Saturdays, Sundays and public holidays. If animals were in a moribund state, they were sacrificed and necropsied.
DETAILED CLINICAL OBSERVATIONS: Yes
A cageside examination was conducted at least once daily for any signs of morbidity, pertinent behavioral changes and signs of overt toxicity. Abnormalities and changes were documented for each animal.
The parturition and lactation behavior of the dams was generally evaluated in the morning in combination with the daily clinical inspection of the dams. Only particular findings (e.g. disability to deliver or umbilical cord not cut) were documented on an individual dam basis.
On weekdays (except public holidays) the parturition behavior of the dams was inspected in the afternoons in addition to the evaluations in the mornings.
The day of parturition was considered to be the 24-hour period from about 15:00 h of one day until about 15:00 h of the following day. Deviations from this procedure were on Saturdays, Sundays and public holidays.
BODY WEIGHT:
In general, the body weight of the male and female parental animals was determined once a week at the same time of the day (in the morning).
The body weight change of the animals was calculated from these results.
The following exceptions are notable for the female parental animals:
• During the mating period, the females were weighed on the day of positive evidence of sperm (GD 0) and on GD 7, 14 and 20.
• Females showing no positive evidence of sperm in the vaginal smear were weighed once a week during this mating interval as were the males.
• Females with litter were weighed on the day of parturition (PND 0) and on PND 4.
• Females without litter were weighed once a week.
• Females between PND 4 and sacrifice were weighed once a week.
FOOD CONSUMPTION:
Generally, food consumption was determined once a week (in a period of 7 days) for male and female parental animals, with the following exceptions:
• Food consumption was not determined after the 2nd premating week (male parental animals) and during the mating period (male and female parental animals).
• Food consumption of the females with evidence of sperm was determined for GD 0-7, 7-14 and 14-20.
• Food consumption of the females, which gave birth to a litter, was determined for PND 1-4.
Food consumption was not determined in the females without positive evidence of sperm during mating and gestation periods and in the females without litter during lactation period. - Sacrifice and pathology:
- Necropsy
All F0 parental animals were sacrificed by decapitation under isoflurane anesthesia. The exsanguinated animals were necropsied and assessed by gross pathology. Animals which have died intercurrently or were sacrificed in a moribund state were necropsied as soon as possible after their death and assessed by gross pathology.
Organ weights
Weight assessment was carried out on all animals sacrificed at scheduled dates. The following weights were determined:
1. Anesthetized animals
2. Epididymides
3. Testes
4. Ovaries
Organ/tissue fixation
The following organs or tissues of parental animals were fixed in 4% neutral buffered formaldehyde solution or in modified Davidson’s solution:
1. All gross lesions
2. Adrenal glands
3. Epididymides (fixed in modified Davidson’s solution)
4. Ovaries (fixed in modified Davidson’s solution)
5. Pituitary gland
6. Prostate gland, seminal vesicles, coagulation glands
7. Skin treated
8. Skin untreated
9. Testes (fixed in modified Davidson’s solution)
10. Uterus, oviducts, vagina
The liver, ovaries, testes and epididymides of animals that died or were sacrificed intercurrently were fixed in 4% buffered formaldehyde solution.
Histopathology
After the organs were fixed, histotechnical processing and examination by light microscopy were performed according to the following table:
Organs Test groups
0 1 2 3
All gross lesions A2 A2 A2 A2
Epididymides A1 A1
Ovaries A1 A1
Skin treated A1 A1 A1 A1
Skin untreated A1 A1
Testes A1 A1
A = hematoxylin and eosin stain
1 = all animals per group
2 = all animals affected per group
Animals that have died or were sacrificed in a moribund state were processed histotechnically and assessed like control animals.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Dermal irritation:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Details on results:
- Clinical observations for males
For males, several dermal findings were noted in test groups 3 (450 and 300 mg/kg bw/d). Starting on study day 10, 5 rats showed focal and multifocal red spots on treated skin on several days. Starting on study day 11, 9 male rats showed focal scales on treated skin on several days. One rat showed focal erosion on treated skin on several days beginning on study day 14. Starting on study day 15, 5 rats showed slight erythema on treated skin onseveral days.
Similar findings but less pronounced were observed in male animals of test group 2 (150 mg/kg bw/d), i.e. focal red spots on treated skin on several days in 5 animals from study day 9 onwards, focal scales on treated skin starting on study day 13 in 2 animals and slight erythema on treated skin in 3 animals starting on study day 15.
No treatment-related findings were observed in male animals of test group 1 (50 mg/kg bw/d).
Clinical observations for females
As observed for the male animals of test group 3 (450 and 300 mg/kg bw/d) different dermal findings on treated skin were noted on several days, i.e. during premating, mating and lactation periods. Starting on study day 3, seven animals showed slight and moderate erythema on several days of the study. In addition, some animals of test group 3 (450 and 300 mg/kg bw/d) showed multifocal, focal and diffuse scales on treated skin starting on study day 5.
Similar findings but less pronounced were observed in female animals of test group 2 (150 mg/kg bw/d), i.e. focal red spots, slight erythema and focal scales on treated skin on several days of the study.
In test group 1 (50 mg/kg bw/d) slight erythema as well as focal and diffuse scales on treated skin were observed in individual animals at different time points.
One female of test group 3 (450 and 300 mg/kg bw/d), which did not deliver pups, showed a vaginal hemorrhage 27 days after mating.
In one female animal of test group 2 (150 mg/kg bw/d) a severe thoracal injury was observed during premating. It was a self inflicted injury which was caused by the animal’s attempt to get rid off the gauze. The injury became more severe by time and the animal had to be sacrificed in a moribund state in study week 1. A red-brown lesion was noted on the thorax of this animal, which correlated to an erosion/ulcer on the skin.
Histopathology
Lymphocytic infiltrates were observed in treated skin sections which were distributed in an interface pattern (10/10 males and 5/10 females at 450 mg/kg bw/d [test group 3] graded minimal to slight, 7/10 males at 150 mg/kg bw/d [test group 2] graded minimal, 2/10 males at 50 mg/kg bw/d [test group 1] graded minimal). All other findings noted were single observations which were considered to be incidental and spontaneous in origin and without any relation to treatment.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day (actual dose received)
- Sex:
- male/female
- Basis for effect level:
- other: The only effect seen was skin irritation.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The dermal administration of Geraniol Extra revealed only local signs of toxicity in male and female Wistar rats at all dose levels. This finding was related to the irritating potential of the test substance.
Thus, concerning toxicity to reproduction the test substance does not need to be classified neither according to Dir 1999/45/EC nor to Reg (EC) 1272/2008. - Executive summary:
Geraniol Extra was administered via dermal administration to groups of 10 male and 10 female Wistar rats (F0 animals) at dose levels of 0 (vehicle control; test group 0), 50 (test group 1), 150 (test group 2) and 450 mg/kg bw/d (test group 3) in order to observe the possible effects of the test substance on the integrity and performance of the reproductive system in both sexes. Due to severe dermal findings, the dose level for test group 3 was decreased to 300 mg/kg bw/d from study day 10 onwards.
Regarding clinical examinations, only signs of local dermal toxicity were observed for males and females at all dose levels. No changes in food consumption and body weight data were seen at any dose level.
Fertility indices for male and female animals were not impaired by test-substance administration.
Regarding pathology, there were no treatment-related necropsy or histological findings in ovaries, testes or epididymides associated with dermal administration of the test substance. The local minimal inflammatory reactions in the skin of treated males (test groups 1-3) and females (test group 3 only) were regarded as related to treatment and adverse.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
